For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Amphenol Corp (APH) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-08): Designation Watch · Gem Score +10 (−100…+100 Quality+Value blend) · Quality 70 · Value -30 · Sentiment 39 (timing only, not weighted) · Composite fair value $89.35 vs $78.36 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Amphenol Corp
APH NYSEAmphenol Corp. Class A Common Stock represents ownership in Amphenol Corp., a global manufacturer of interconnect and sensor technologies. Amphenol designs, manufactures, and markets electrical, electronic, and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products, and specialty cable used across a wide range of applications. The company serves markets including communications, industrial, automotive, aerospace and defense, broadband, mobile devices, and information technology, making it an important supplier to many electronic systems and networked platforms. Amphenol operates through segments such as Communications Solutions, Harsh Environment Solutions, and Interconnect and Sensor Systems, which support customers that require reliable connectivity, signal transmission, and ruggedized components. Headquartered in Wallingford, Connecticut, and founded in 1932, Amphenol Corp. is a diversified industrial technology company with a broad presence in global electronics supply chains.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics TTM · through Jun 30, 2026
EPS (Diluted): 4.00
Total Equity: $15.62B
Shares: 1,287,233,333
Total Debt: $18.81B
Cash: $4.73B
EBITDA: $9.15B
Total Debt: $18.81B
Cash: $4.73B
Revenue: $29.01B
Revenue: $29.01B
Revenue: $29.01B
Total Equity: $15.62B
Tax Rate: 29.2%
Equity: $15.62B
Total Debt: $18.81B
Cash: $4.73B
Current Liabilities: $9.44B
Long-Term Debt: $17.18B
Total Debt: $18.81B
Total Equity: $15.62B
Shares: 1,287,233,333
Shares: 1,287,233,333
CapEx: -$1.16B
Shares: 1,287,233,333
Stock Price: $78.36
Net Income: $5.14B
Industry Benchmarks
Income Statement (Annual)
Last updated: Sep 10, 2026 12:07pm (28d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $10.9B | $12.6B | $12.6B | $15.2B | $23.1B |
| Cost of Revenue | $7.5B | $8.6B | $8.5B | $10.1B | $14.6B |
| Gross Profit | $3.4B | $4.0B | $4.1B | $5.1B | $8.5B |
| Operating Expenses | $1.3B | $1.4B | $1.5B | $2.0B | $2.6B |
| Operating Income | $2.1B | $2.6B | $2.6B | $3.2B | $5.9B |
| Net Income | $1.6B | $1.9B | $1.9B | $2.4B | $4.3B |
| EBITDA | $2.5B | $3.0B | $3.0B | $3.7B | $6.8B |
| EPS | $1.29 | $1.54 | $1.56 | $2.01 | $3.51 |
| EPS (Diluted) | $1.23 | $1.48 | $1.50 | $1.92 | $3.34 |
Balance Sheet (Annual)
Last updated: Sep 10, 2026 12:07pm (28d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.2B | $1.4B | $1.5B | $3.3B | $11.1B |
| Total Current Assets | $6.0B | $6.5B | $6.8B | $9.7B | $20.3B |
| Total Assets | $14.7B | $15.3B | $16.5B | $21.4B | $36.2B |
| Current Liabilities | $2.4B | $2.7B | $3.2B | $4.1B | $6.8B |
| Long-Term Debt | $4.8B | $4.6B | $4.0B | $6.5B | $14.6B |
| Total Liabilities | $8.3B | $8.2B | $8.1B | $11.6B | $22.7B |
| Total Equity | $6.4B | $7.1B | $8.4B | $9.9B | $13.5B |
| Retained Earnings | $4.3B | $5.0B | $5.9B | $7.1B | $9.9B |
Cash Flow (Annual)
Last updated: Sep 10, 2026 12:07pm (28d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $2.2B | $2.5B | $2.8B | $5.4B |
| Capital Expenditure | -$360.4M | -$383.8M | -$372.8M | -$665.4M | -$996.6M |
| Free Cash Flow | $1.2B | $1.8B | $2.2B | $2.1B | $4.4B |
| Acquisitions (net) | -$2.2B | -$288.2M | -$970.4M | -$2.2B | -$3.8B |
| Net Debt Issued / (Repaid) | -$160.5M | -$4.5M | $339.2M | $2.6B | $8.5B |
| Dividends Paid | -$346.7M | -$477.4M | -$500.6M | -$595.1M | -$802.2M |
| Stock Buybacks | -$661.7M | -$730.5M | -$585.1M | -$689.3M | -$665.2M |
| Net Change in Cash | -$504.9M | $176.0M | $101.9M | $1.8B | $7.8B |
Growth Trends (YoY %)
Last updated: Sep 10, 2026 12:07pm (28d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +16.1% | -0.5% | +21.3% | +51.7% |
| Gross Profit Growth | +18.4% | +1.4% | +25.8% | +65.7% |
| Operating Income Growth | +22.8% | -1.0% | +23.3% | +85.9% |
| Net Income Growth | +19.6% | +1.4% | +25.7% | +76.2% |
| EBITDA Growth | +19.1% | -0.4% | +25.7% | +82.1% |
Dividend History (Last 20)
Last updated: Sep 17, 2026 4:14pm (20d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-23 | $0.25 | — | — | — |
| 2026-03-23 | $0.25 | — | — | — |
| 2025-12-16 | $0.25 | — | — | — |
| 2025-09-16 | $0.17 | — | — | — |
| 2025-06-17 | $0.17 | — | — | — |
| 2025-03-18 | $0.17 | — | — | — |
| 2024-12-17 | $0.17 | — | — | — |
| 2024-09-17 | $0.17 | — | — | — |
| 2024-06-18 | $0.11 | — | — | — |
| 2024-03-18 | $0.22 | — | — | — |
| 2023-12-18 | $0.22 | — | — | — |
| 2023-09-18 | $0.21 | — | — | — |
| 2023-06-16 | $0.21 | — | — | — |
| 2023-03-20 | $0.21 | — | — | — |
| 2022-12-19 | $0.21 | — | — | — |
| 2022-09-19 | $0.20 | — | — | — |
| 2022-06-17 | $0.20 | — | — | — |
| 2022-03-21 | $0.20 | — | — | — |
| 2021-12-20 | $0.20 | — | — | — |
| 2021-09-20 | $0.15 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-10-02 02:03A +1σ run of quarters pays -11%; a −1σ run costs 55%. Ratio -0.2:1 (μ 44.8%, σ 18.8% , 16 pairs).
Older method (repeat-worst-quarter): 9.1 : 1
| Case | Growth | Margin | Fair value | vs price ($78.36) |
|---|---|---|---|---|
| Bull — recovery | +86% | 20.4% | $167.11 | +113% |
| Base — stabilizes | +57% | 17.7% | $76.69 | -2% |
| Bear — keeps slipping | +29% | 15.1% | $31.77 | -59% |
| Stress — last quarter repeats | +49% | 19.5% | $68.57 | -12% |
| Upside — a +1σ run of quarters (v2) | +50% | 19.5% | $70.09 | -11% |
| Stress — a −1σ run of quarters (v2) | +26% | 18.2% | $34.91 | -55% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-09-17 16:24The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The raw quarterly trajectory here is genuinely striking and deserves first scrutiny before any model verdict. TTM revenue moved from $15.22B (FY24) to $23.09B (FY25) to what looks like a $28.8B annualized run-rate by Q2'26 ($8.76B quarter). That's not organic — Amphenol closed the Andrew (CommScope CCS) acquisition in early 2025, which explains the step-function. The 47% "CAGR" and 54% YoY numbers the momentum model spits out are mechanical artifacts of M&A, not underlying demand — a careful reader should discount them heavily. That said, the Q2'26 print of $8.76B rev / 20.2% net margin is legitimately strong; sequential growth from $6.19B (Q3'25) to $8.76B (Q2'26) is roughly 41% in three quarters, well beyond deal contribution alone, consistent with the AI/datacenter connector cycle Amphenol has explicitly called out.
On valuation, the synthesis composite of $89 fair value and signal-adjusted $126 (+61%) strikes me as aggressive and probably naive to the M&A distortion. At $78.36 and $190B market cap on TTM earnings around $5.15B (summing the last four quarters), the trailing P/E is ~37x, not the 19.6x FMP tile suggests — the FMP TTM tag looks stale or mis-windowed given the Q2'26 earnings jump. EV/EBITDA at ~12x is more defensible but still full for a components maker with $15.5B debt against $11.1B cash (net debt ~$4.4B, modest). ROIC of 18.7% and ROE of 37.8% are genuinely elite for the industry, and FCF of $4.38B on FY25 (likely $5.5B+ TTM) supports a premium. But a fair-value near $126 requires believing the AI/datacenter connector boom sustains 20% net margins indefinitely — that's the peak-cycle assumption baked into every hyperscaler-adjacent name right now.
The contrarian read: APH's Q1'26 margin dipped to 12.2% (vs. 20%+ neighbors) — that's a $933M NI print in a quarter with $7.62B rev, suggesting either integration charges, one-timers, or genuine margin volatility that the bull case waves away. The insider activity is entirely A-Awards (grants, not open-market buys) dated 2026-05-22 — this is compensation vesting, not a signal. Zero insider buying at these levels is mildly telling given the stock has clearly run. The narrative model correctly flags this as "quiet-quality" with fundamentals-anchored pricing, but pricing at 37x trailing GAAP earnings for a cyclical connector business — even a best-in-class one — leaves no margin of safety if datacenter capex normalizes in 2027. Berkshire exited APH years ago; the "hidden compounder" framing is dated.
I dissent from the synthesis "undervalued +61%" verdict. The composite is being fooled by TTM data windows that mix pre- and post-Andrew acquisition periods, inflating growth rates and depressing apparent multiples. My read: APH is a high-quality business trading at a full-to-rich multiple on peak-cycle margins, benefiting from a real but cyclical AI infrastructure tailwind. Fair value sits closer to $70–85 on normalized 16–17% net margins and 15% forward earnings growth — roughly where it trades. Not a short (business quality and secular tailwinds are real), but the +61% upside claim is model artifact, not signal. The pre-flight thesis identifying M&A as the driver of the revenue jump is the most honest piece of analysis in the stack; the valuation synthesis ignored its own colleague's warning.
GPT Reading
Amphenol’s raw numbers say this is not a sleepy “mature earner” right now; it is a premium industrial-tech franchise in the middle of a step-change. Trailing revenue through 2026-06-30 is $29.0B, up roughly 58% from the prior trailing period of about $18.4B, while trailing net income is $5.15B, up about 50% from roughly $3.43B. That is not just accounting noise: the quarterly progression from $4.04B of revenue in 2024-09 to $8.76B in 2026-06 is too large and too sustained to dismiss. Even if acquisitions drove much of the jump, the striking part is that profitability held up. On the trailing numbers, gross margin is 38.5%, operating margin 27.0%, and net margin 17.7%, all very strong for a components manufacturer absorbing major growth. The March 2026 quarter is the obvious blemish, with net margin dropping to 12.2%, but that already looks more like an integration or one-time cost pocket than a structural deterioration given the immediate rebound to 20.2% in June.
At $78.36 and a $190.5B market cap, the stock does not screen cheap in absolute terms, but the multiple set is more reasonable than the premium quality of the business. A 19.6x trailing P/E on $5.15B of TTM earnings and about 12.0x EV/EBITDA for a company compounding this fast, while still converting cash well, is not demanding. The balance sheet is also better than the headline debt-to-equity might imply: $15.5B of debt against $11.1B of cash leaves only about $4.4B of net debt, which is trivial relative to a business producing $5.37B of operating cash flow and $4.38B of free cash flow on the latest annual base, and likely more on the current trailing run-rate. ROIC at 18.7% and ROE near 37.8% suggest this is still a very efficient allocator even after the apparent acquisition-led expansion. To me, the key point is that the market is still valuing Amphenol more like a high-quality cyclical than a scaled platform with secular exposure to data centers, automotive electrification, and aerospace, despite the evidence that earnings power has materially reset upward.
The strongest argument against this bullish read is that investors may be annualizing a one-off acquisition bulge and giving management full credit before integration risk has truly passed through the model. Revenue leapt from $15.22B in 2024 to $23.09B in 2025 on the annual numbers, and then to a $29B trailing run-rate by mid-2026; when a company grows that quickly by dealmaking, margins can look temporarily flattered by purchase accounting, mix, or short-cycle demand strength. The March 2026 profit dip matters because it may be the first glimpse of normalized earnings after a very favorable close-and-harvest period. And while 19.6x trailing earnings sounds fine, it is less obviously cheap if those earnings are near a cyclical peak and if organic growth is much lower than the headline 50%+ rates. Price-to-sales at 3.48x and price-to-book at 6.46x are not bargain multiples for an electronics supplier if the market is late-cycle and macro headwinds bite.
I still weigh the evidence positively because the company’s margin structure is too strong and too consistent to fit the “commodity connector cycle” bear case. Even after the strange March quarter, Amphenol delivered $1.77B of net income on $8.76B of sales in June, versus $1.09B on $5.65B a year earlier; that is 55% revenue growth with 62% earnings growth year over year in the most recent quarter. If this were merely bought revenue with deteriorating quality, I would expect gross and operating margins to sag more meaningfully, but the trailing margins remain elite. The dividend payout ratio under 20% also matters: management has room to keep compounding via reinvestment, acquisitions, and buybacks rather than supporting an overextended payout. The valuation synthesis calling the stock deeply undervalued may be too aggressive, but I think the simpler conclusion is enough: this is a legitimately better business than the stock’s “traditional manufacturer” framing suggests, and the current price does not fully reflect the higher earnings base unless profits roll over soon.
What would change my mind is straightforward. If the next two quarters show revenue stalling below roughly $8B per quarter while net margin stays in the low-to-mid teens, then the June rebound was probably temporary and the stock is closer to fairly valued or expensive at nearly 20x trailing earnings. Likewise, if free cash flow fails to scale toward at least $5B+ on the enlarged revenue base, I would worry the acquisition-driven growth is lower quality than it appears. On the other hand, if Amphenol can hold operating margin around 26%-27% and sustain even low-teens organic-style growth off this much larger base, then $78 will look like an undemanding entry for a business whose normalized earnings power is still being revised upward.
Grok Reading
Amphenol’s numbers describe a cash-compounding industrial that has been re-rated by scale rather than by narrative. Trailing-twelve-month revenue through mid-2026 runs at roughly $29.0B (sum of the four most recent quarters), up from the $23.1B full-year 2025 print and nearly double the $15.2B of 2024; sequential quarters have climbed 6.19 → 6.44 → 7.62 → 8.76B with year-ago growth still above 50 percent. Net income over the same window is about $5.15B, implying a mid-to-high-teens net margin that matches the reported 17.7 percent TTM figure, while operating margin sits at 27 percent and ROE at 38 percent. Free-cash-flow conversion remains clean—2025 produced $4.38B of FCF after less than $1B of capex—and net debt is modest once the $11.1B cash pile is netted against $15.5B of gross debt. At $78.36 the stock screens at 19.6× trailing earnings, 12× EV/EBITDA and 3.5× sales; those multiples are not demanding for a business that has just delivered a 47 percent revenue CAGR and is still printing mid-teens-plus sequential growth while expanding into data-center, EV and aerospace interconnect content. The story the ledger tells is therefore straightforward: a mature earner that absorbed a large acquisition (the 2024-to-2025 revenue step-function), kept margins intact, and is now running at a higher absolute earnings base that the market has only partially capitalized.
The sharpest internal tension is the Q1 2026 net-margin collapse to 12.2 percent ($933M on $7.62B) against the 18–20 percent band that brackets every other recent quarter. That single soft print, together with the secondary “decelerating revenue confidence” flag, is the clearest quantitative warning that integration costs, mix, or one-time items can still dent reported profitability even while top-line momentum looks uninterrupted. Debt-to-equity at 1.2× is also higher than the fortress balance sheets typical of pure compounders, and the entire 2025–2026 growth burst is still young enough that organic versus acquired contribution cannot yet be cleanly separated. If the true GAAP multiple on the $5.15B of reported TTM net income is closer to the mid-30s once share count is reconciled, the cheapness signal from the 19.6× PE screen weakens materially and the stock starts to look merely fairly valued for a cyclical electronics supplier rather than cheap for a secular compounder.
A disciplined skeptic would therefore argue that $78 already embeds the easy part of the acquisition story and that any reversion toward mid-single-digit organic growth plus normalized 15–16 percent net margins would leave the shares expensive on mid-cycle earnings. They would also note that the valuation-synthesis engine itself flags “methods disagree” and then leaps from a $89 composite to a $126 signal-adjusted target—an internal inconsistency that undercuts the 61 percent upside claim. Insider activity is pure award noise, offering no corroboration of undervaluation, and macro headwinds remain an explicit secondary signal. I weigh those objections seriously but still subordinate them to the combination of 27 percent operating margins, sub-12× EV/EBITDA, and a free-cash-flow machine that has scaled without destroying returns on capital; the margin dip looks more like a one-quarter anomaly than a structural break, and the absolute earnings power now supporting the equity is simply larger than it was eighteen months ago.
The verdict flips if two consecutive quarters show sequential revenue declines or if net margin settles below 15 percent while free-cash-flow conversion deteriorates; equally decisive would be explicit disclosure that the 2025 revenue step-up is failing to deliver the expected cost or cross-sell synergies, or a sharp cutback in hyperscale and auto-electrification capex that removes the secular demand props. Until those prints appear, the data favor owning the shares below $85–90 on a quality-growth basis.
Qwen Reading local experiment · off-panel
The most glaring anomaly in this dataset is not the valuation multiple, but the sheer velocity of the revenue expansion, which appears to contradict the "mature earner" classification assigned by the rule-based model. Amphenol’s revenue jumped from $15.22B in 2024 to $23.09B in 2025, a 51.7% increase in a single year, followed by a Q1 2026 revenue print of $7.62B that implies a run-rate significantly higher than the prior year's average. This is not the profile of a "boring" industrial compounder; it is the profile of a company undergoing a massive inorganic transformation or a hyper-growth phase in data center and EV connectivity. The "Momentum" section cites a 47.2% revenue CAGR, which is mathematically impossible for a company of this size without massive M&A, yet the "Market Narrative" describes APH as a "quiet-quality" stock with "minimal" narrative intensity. This is a direct contradiction. A 50%+ revenue jump in a single year for a $190B market cap company generates significant narrative heat, integration risk, and dilution concerns that the "quiet" label ignores. The data suggests the market is currently pricing in a successful, high-velocity integration story, not a steady-state industrial.
The valuation metrics provided are internally inconsistent with the growth rates, suggesting the "undervalued" verdict from the Valuation Synthesis is dangerously optimistic. At a P/E of 19.6x and EV/EBITDA of 12.0x, the stock is trading at a discount to its historical premium, but this discount is justified by the fact that the earnings base has been artificially inflated by recent acquisitions. The net margin of 17.7% (TTM) is solid, but the operating margin of 27.0% is suspiciously high for a hardware manufacturer, likely reflecting one-time gains or aggressive accounting in the acquisition period. The "Pre-Flight Intelligence" notes a "38% discount to DCF," but this DCF likely assumes a mean-reversion of growth rates that the current data does not support. If the 50%+ growth rate is sustainable, the P/E is cheap; if it is not, and the company reverts to 5-10% organic growth, the 19.6x P/E is expensive for a cyclical industrial. The "Mature Earner" archetype is a misclassification; this is a "Growth Industrial" with high execution risk.
The strongest case against my skepticism of the "undervalued" label is the quality of the cash flow. Free cash flow of $4.38B against a market cap of $190B yields a FCF yield of ~2.3%, which is low, but the operating cash flow of $5.37B is robust. The balance sheet shows $11.13B in cash against $15.50B in debt, a net debt position of only $4.37B, which is manageable. The ROIC of 18.7% is excellent, indicating that the capital deployed in acquisitions is generating high returns. The "Insider Transactions" show only "A-Award" grants, which are standard compensation and not indicative of insider selling or buying, so this signal is neutral. The "Macro Headwinds" signal is a risk, but Amphenol’s diversification across aerospace, automotive, and data centers provides a hedge. The "Above Sector Benchmarks" signal supports the idea that APH is outperforming peers, which justifies a premium multiple. However, the "Decelerating" quarterly trend in revenue confidence is a red flag that the 50% growth rate may be peaking.
The "Market Narrative" layer is the most misleading part of the briefing. It describes APH as a "no story" compounder, but the data shows a company in the midst of a major transformation. The "Bull story" cites "5G, EV proliferation, data center buildout," which are real secular trends, but the "Bear story" cites "China exposure" and "cyclical margin compression." The data does not support the "quiet" narrative; the revenue jump is too large to be quiet. The "Valuation Synthesis" verdict of "undervalued" with a composite fair value of $89.35 is likely based on a DCF that assumes the high growth rate continues, which is a risky assumption. The "Signal-adjusted" value of $126.38 is even more optimistic, suggesting a 61% upside, which is unrealistic for a $190B company without a major catalyst. I believe the market is correctly pricing in the risk of growth deceleration and integration challenges, and the "undervalued" verdict is overconfident.
What would change my mind is a confirmation of organic growth. If the next two quarters show revenue growth of 15-20% on an organic basis (excluding acquisitions), it would validate the "Growth Industrial" thesis and justify a higher multiple. Conversely, if the revenue growth decelerates to single digits, the 19.6x P/E becomes expensive, and the stock is likely overvalued. The "Insider Activity" is neutral, so I am not seeing any insider conviction. The "Macro Headwinds" are a risk, but the "Above Sector Benchmarks" signal suggests APH is resilient. The key is the sustainability of the 50%+ revenue growth. If it is driven by M&A, the market should be discounting the stock for integration risk and dilution. If it is driven by organic demand, the stock is undervalued. The data does not clearly distinguish between the two, but the "Decelerating" trend suggests the former.
Big-3 Panel — where each AI stands
Claude — Second Response · overvalued held
VERDICT: Holding overvalued at $163; fair value $140-150 on normalized 15-16% margins and peer-appropriate 28-32x multiple; revisit only if Q2/Q3 2026 print >17% net margin on sustained $7B+ revenue.
GPT's reading essentially arrived at my conclusion by a different route — same skepticism on the 12.2% Q1 margin, same rejection of the synthesis "undervalued" verdict, same fair value band ($110-130 vs my $135-145). The convergence there is reinforcing, not moving. The interesting argument is Grok's, because Grok saw the same margin collapse I did and still landed at $200-220 fair value by treating Q1 as likely deal-related noise and anchoring on run-rate revenue with normalized margins. That's the bull case stated honestly, and I want to engage it rather than dismiss it.
Here's what didn't move me: Grok's fair value math requires *both* that Q1 margin compression is transitory *and* that a $30B revenue run-rate is durable. Those are two independent bets, each maybe 60-70% likely, and the joint probability is closer to 40-50% — not high enough to justify paying 49x trailing when the downside case (structural margin reset to 13-15%) implies $110-120. Asymmetry favors the skeptic here. Grok also concedes the exact tripwire I'd use — "flip to overvalued if next two quarters show margins stuck in low teens" — which means we agree on the test, we just disagree on the prior. Given that the *most recent* datapoint is the low-teens print, the correct Bayesian prior is skepticism until proven otherwise, not the reverse.
What genuinely gave me pause: Grok's point that $4.38B FCF on $997M capex is real cash, not accrual accounting, and cash conversion that clean is hard to fake with acquisition noise. That tempers my confidence that the Q1 margin drop reflects underlying deterioration rather than deal accounting — it's more likely a step-up amortization or transaction charge than genuine economic compression. I'll acknowledge that pushes my fair value band up modestly, toward $140-150 rather than $135-145. But it doesn't close the gap to $163, and it certainly doesn't get me to Grok's $200+. I'm holding overvalued with slightly reduced conviction, and the falsification test is explicit: two quarters of 17%+ net margin on $7B+ revenue and I revise.
GPT — Second Response · overvalued revised
VERDICT: Still overvalued at $163; elite franchise and possible secular re-rating, but until margins recover from 12.2% toward 17%+, fair value is roughly $130-$145.
Claude’s critique largely reinforces my original view rather than moving me off it. The strongest point he adds is not “AI premium is excessive” — I already thought that — but that the apparent net-cash/zero-debt picture may be a data artifact, which would make the EV-based valuation look slightly less flattering and weaken part of the “fortress balance sheet” comfort. More importantly, he sharpened the core inconsistency: if you annualize the bigger revenue base but continue to use 2025’s ~19% net margin, you are effectively importing peak profitability into a quarter that printed 12.2%. That is exactly the hidden assumption I was resisting. I also agree the insider “buying” is non-informative compensation noise. None of that changes my direction; it modestly increases conviction.
Grok’s pushback is the only thing that gave me pause, specifically the argument that APH may have structurally migrated from a cyclical connector roll-up into a scarcer AI/electrification interconnect platform, which could make static peer comps too conservative. If the company can hold something like a $28B-$30B revenue run-rate and recover margins into the high teens, today’s multiple would compress quickly and my prior $120-$130 range could prove too harsh. That said, the argument still depends on a margin normalization we have not yet seen. The latest quarter is not a small wobble; it is a material break in incremental profitability at the exact moment the stock is priced for excellence. So I am revising only in degree, not direction: I’ll concede the quality/secular mix may justify a somewhat higher fair range than my first pass, but not enough to make $163 attractive before the margin bridge is proven.
Grok — Second Response · overvalued changed direction
VERDICT: Elite franchise but modestly overvalued at $163; fair value $140-155 until margins prove they can re-expand above mid-teens
The colleagues’ sharp focus on the Q1 margin break forces a recalibration. Both correctly note that net income fell 25% sequentially even as revenue jumped 23% to $7.62B, dropping the net margin to 12.2% from the prior 19-20% band; Claude’s observation that any DCF still extrapolating 18-19% margins against the new revenue base is simply invalid is decisive. GPT’s parallel math—that even a generous $4.8-5.0B forward earnings leaves the stock at ~40x—lands harder than my original “if margins normalize” framing. I underweighted how quickly the multiple becomes indefensible if the compression is mix- or acquisition-driven (Andrew/CommScope timing fits) rather than purely temporary. Peer context seals it: TE Connectivity at ~20x makes the 49x premium look like peak AI-infrastructure scarcity pricing, not prepaid compounder economics.
I still reject the lower $120-130 fair-value anchors as too punitive; the fortress FCF conversion, 25%+ operating margins on the full-year base, zero-debt (or near-zero) balance sheet, and genuine AI/electrification content ramp remain elite and justify a structural premium over traditional connector peers. But the burden of proof has flipped: two clean quarters of margin recovery above 17% on a $28B+ run-rate would restore the $200 path; absent that evidence the current tape already prices perfection. The insider “buying” noise and any ROIC artifacts further weaken the quality overlay I originally leaned on. Net result is a clear revision away from modest undervaluation.
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has scaled from $11.93B in 2022 to $29.01B on a TTM basis through mid-2026, a step-change that includes both organic acceleration and clearly meaningful M&A. Alongside that top-line, gross margin expanded from 31.5% to 38.5% and operating margin from 20.1% to 27.0% - genuine operating leverage, not just mix. Net income roughly tripled to $5.14B and FCF grew to $4.71B, with OCF/NI of 1.16x and accruals at -1.9% of assets confirming the earnings are cash-backed. Beneish M of -2.11 and Altman Z of 5.73 signal no manipulation or distress flags., Capital discipline is a standout: diluted share count is essentially flat at ~1.29B over five years, SBC is only 0.5% of revenue, and buybacks run 610% of SBC - per-share value is being protected while the business grows. The main constraint is the balance sheet: net debt of ~$13.4B against $5.42B cash, which reflects acquisition-funded growth. Given $4.71B annual FCF, leverage is very serviceable (roughly 2.8x FCF) but it is a constraint rather than a cushion. Insider activity is neutral - routine awards and modest sales ($18.7M), no directional signal. Nothing in the raw tape contradicts the modules; the quality picture is consistently good.
Verify before trusting this (5)
- Organic vs acquired revenue split in the FY2024-2026 jump from $13.4B to $29.0B
- Details of the debt stack: maturities, fixed vs floating, covenants
- Customer/end-market concentration (esp. AI/datacom exposure) in latest 10-K
- Whether margin expansion is mix-driven (IT datacom) or broad-based across segments
- Goodwill and intangibles balance vs equity given acquisitive strategy
Price is $78.36 against a composite fair value of $89.35 (about 14% upside) and a DCF of $69.85 (about 11% downside). The signal-adjusted $126 and anchored-PE $209 are runaway outputs I discount heavily - they imply a 27x+ multiple justified purely by recent growth acceleration, which the Quality lens itself flags as likely M&A-driven and non-repeatable. Stripping those, the credible deserved-value band is roughly $70-95, centered near the current quote. The EPV floor of $8 is also non-informative (capitalizes a stripped-down earnings base) and I ignore it as a downside anchor.
Verify before trusting this (5)
- Organic vs acquired revenue split in the recent growth acceleration
- Net debt trajectory and integration costs from recent M&A
- Data-center/AI revenue mix and durability of that pricing
- China revenue exposure and any guidance on tariff/decoupling impact
- Free cash flow conversion excluding working-capital swings
Sentiment pressure on APH is net positive. The active narrative has quietly shifted from 'boring connector supplier' to 'AI infrastructure pick-and-shovel,' with recent news flow tagging it alongside Vertiv, NVT and Corning as an AI-datacom beneficiary, a Zacks #1 momentum call, and multiple 'undervalued on cash flow' framings. That is exactly the kind of story analysts and momentum funds want to own right now, and it is landing on a stock that has already compounded at a 47% CAGR with recent action even hotter. Against that, the tape just turned mildly risk-off (VIX 17.7, S&P -3% from highs) and APH's 1.24 beta means it will feel any broader de-risking; the -6.4% one-day drop on Sept 14 and the Fabrinet-driven -6.6% in August show the stock is treated as part of the high-beta AI optical/datacom complex and can be whipsawed by any crack in that theme. Analyst tone is constructive but not euphoric - debates about 27x P/E being 'overvalued' vs 10% undervalued on DCF suggest a healthy two-sided book rather than a mania. Net: a durable, strengthening AI narrative on a high-momentum name, lightly pressured by a nascent risk-off tape - a real, but not decisive, tailwind.
Verify before trusting this (4)
- Whether any AI-infrastructure peer (Fabrinet, Coherent, Vertiv) prints a disappointment that triggers basket-wide de-rating
- VIX trajectory - does the risk-off score deepen past -50 or fade back to neutral within a week
- Sell-side target revisions into Q3 print - are estimates still moving up or starting to flatten
- Any crack in the AI datacom capex narrative from hyperscaler commentary that would puncture the pick-and-shovel story
The world is rebuilding compute, and every watt and bit in an AI rack crosses a connector. That physical-layer toll is the cleanest non-semiconductor exposure to the capex cycle, and Amphenol owns more of it than anyone. The broader electronics complex is only mildly expanding with falling earnings — proof this is not a tide lifting all boats but a content shift toward interconnect-intensive architectures, with Amphenol plus M&A capturing it. The offsets are macro-shaped: high long rates, tariff and China frictions, and softer industrial/mobile demand. Two to three years out, the question is not whether AI interconnect demand exists but whether spending grows off a vastly larger base; content-per-rack gains and defense/aero can keep the business compounding at healthy double digits, but nothing like the current rate.
When we made this prediction on Sep 18, 2026, APH was $78.42. We expect it to be $86.00 by Mar 2027, and we consider it great value under $65.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 18, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.